Drug Transporters 2014
DOI: 10.1002/9781118705308.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Overview of Drug Transporter Families

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 44 publications
0
5
0
Order By: Relevance
“…The activity of transporters, however, is not limited only to their physiological substrates but also includes a variety of exogenous compounds. Drugs with structural similarities to endogenous transporter substrates can also be transported across cell membranes thus modulating their absorption, disposition, and elimination …”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The activity of transporters, however, is not limited only to their physiological substrates but also includes a variety of exogenous compounds. Drugs with structural similarities to endogenous transporter substrates can also be transported across cell membranes thus modulating their absorption, disposition, and elimination …”
Section: Introductionmentioning
confidence: 99%
“…The transporters of greatest current interest in drug disposition belong to one of two major classes: ATP-binding cassette (ABC) and solute carrier (SLC) transport families. ABC transporters are primarily active transporters that mediate the efflux of compounds out of cells, , and the overexpression of ABC transporters has long been known to be related to drug resistance. The most studied drug transporters belonging to the ABC family include multidrug resistance protein 1 (MDR1) or P-glycoprotein (P-gp), the multidrug resistance-associated proteins 1–9 (MRPs 1–9), and breast cancer resistance protein (BCRP). The majority of known drug uptake transporters belong to the SLC transporter family.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…160,161 Recent advances in molecular biology have enabled the identification of more than 400 membrane transporters in the human genome, which has contributed to an increased understanding of their expression in specific tissues, their regulation, their mechanisms of transport, their substrates and inhibitors, and species-dependent differences in activity and function. 162 Transporters are involved in the uptake and efflux of endogenous substances including physiological chemicals, nutrients, and ions, but can also transport xenobiotics. Transporters expressed on both the apical and basolateral sides of intestinal enterocytes that can influence the oral absorption of drugs include oligopeptide transporter (PepT), organic anion transporter (OAT), organic cation transporter (OCT), sodium-dependent glucose transporter (SGLT) family, apical sodium-dependent bile acid transporter, monocarboxylate transporter, proton-coupled amino acid transporter, and amino acid transporter ATB° ,+ .…”
Section: Design Of Prodrugs To Improve Oral Absorption and Bioavailab...mentioning
confidence: 99%
“…Transporters expressed on both the apical and basolateral sides of intestinal enterocytes that can influence the oral absorption of drugs include oligopeptide transporter (PepT), organic anion transporter (OAT), organic cation transporter (OCT), sodium-dependent glucose transporter (SGLT) family, apical sodium-dependent bile acid transporter, monocarboxylate transporter, proton-coupled amino acid transporter, and amino acid transporter ATB° ,+ . 160–162 Peptide transporters, especially PepT1, have drawn significant attention in drug discovery since targeting this transporter remains an attractive strategy for improving oral drug delivery based on its abundant expression in the small intestine, high substrate capacity, and broad substrate specificity. These properties are reflected in the PepT1-mediated transport of a wide range of substrates that include dipeptides, tripeptides, β-lactam antibiotics, angiotensin-converting enzyme inhibitors, and antiviral drugs.…”
Section: Design Of Prodrugs To Improve Oral Absorption and Bioavailab...mentioning
confidence: 99%